CONMED Corporation vs. Neuraxis, Inc.
CONMED Corporation (CNMD) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| CNMD | NRXS | |
|---|---|---|
| Market Cap | $1.38 billion | $87.15 million |
| Revenue (TTM) | $1.37 billion | $5.32 million |
| Net Income (TTM) | $56.50 million | $-7,678,631 |
CNMD leads on 3 of 3 size & scale factors.
Valuation
| CNMD | NRXS | |
|---|---|---|
| P/E Ratio | 24.94 | — |
| Price / Book | 1.33 | 12.94 |
| Price / Sales | 1.01 | 16.39 |
CNMD leads on 2 of 2 valuation factors.
Profitability
| CNMD | NRXS | |
|---|---|---|
| Net Margin | 4.12% | -144.44% |
| Return on Equity | 5.43% | -114.01% |
CNMD leads on 2 of 2 profitability factors.
Dividend
| CNMD | NRXS | |
|---|---|---|
| Dividend Yield | 1.73% | — |
| Payout Ratio | 43.24 | — |
CNMD and NRXS split the dividend factors evenly.
Risk & Sentiment
| CNMD | NRXS | |
|---|---|---|
| Short Interest | 2.50% | 0.02% |
NRXS leads on 1 of 1 risk & sentiment factors.
Dig deeper: CNMD overview, CNMD financials, NRXS overview, NRXS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.